| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013; НСР-15268/16.03.2018 |
08.03.2013 |
02.04.2018 |
Заличен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Екофарм ЕООД, България |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017; НСР-13712/01.09.2017 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
02.10.2017 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Екофарм Груп АД, България |
Baxter Oncology GmbH - Germany |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
промяна обстоятелства НСР-13370/28.07.2017 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
02.09.2017 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
41.46 |
8.29 |
49.75 |
4% |
1.66 |
43.12 |
8.62 |
51.74 |
16% |
6.63 |
49.75 |
9.95 |
59.7 |
|
КЦРР-2309/20.02.2013 |
08.03.2013 |
08.03.2013 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1255/ 13.12.2007 |
ENDOXAN, Powder for solution for injection, 200, mg, Pack: 10 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
42.19 |
8.44 |
50.63 |
4% |
1.69 |
43.88 |
8.78 |
52.66 |
16% |
6.75 |
50.63 |
10.13 |
60.76 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
1666 |
| Cyclophosphamide |
II-1256/13.12.2007 |
ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
3.77 |
0.75 |
4.52 |
7% |
0.26 |
4.03 |
0.81 |
4.84 |
20% |
0.75 |
4.78 |
0.96 |
5.74 |
Цената се вписва в регистъра на пределните цени с решение НСР-2722/06.02.2014 |
КЦРР-2309/20.02.2013 |
08.03.2013 |
08.03.2013 |
Заличен |
1667 |
| Cyclophosphamide |
II-1256/ 13.12.2007 |
ENDOXAN, Powder for solution for injection, 500, mg, Pack: 1 |
Baxter Oncolcogy GmbH, Германия |
Baxter Oncology GmbH - Germany |
4.19 |
0.84 |
5.03 |
7% |
0.29 |
4.48 |
0.9 |
5.38 |
20% |
0.84 |
5.32 |
1.06 |
6.38 |
|
КЦ-950/10.06.2009 |
30.06.2009 |
30.06.2009 |
Неактивен |
1667 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.76 |
1.55 |
9.31 |
7% |
0.54 |
8.3 |
1.66 |
9.96 |
20% |
1.55 |
9.85 |
1.97 |
11.82 |
|
НСР-3198/07.04.2014; НСР-9769/14.07.2016 |
21.04.2014 |
02.08.2016 |
Заличен |
2682 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.76 |
1.55 |
9.31 |
7% |
0.54 |
8.3 |
1.66 |
9.96 |
20% |
1.55 |
9.85 |
1.97 |
11.82 |
|
НСР-3198/07.04.2014 |
21.04.2014 |
21.04.2014 |
Неактивен |
2682 |
| Trimetazidine |
20110185 |
Energotrim, Modified release tablet, 35, mg, Pack: 60 |
Sandoz d.d., Словения |
Lupin (Europe)Ltd., Victoria Court, bexton Road, Knutsford, Cheshire, WA160PF, United Kingdom |
7.94 |
1.59 |
9.53 |
7% |
0.56 |
8.5 |
1.7 |
10.2 |
20% |
1.59 |
10.09 |
2.02 |
12.11 |
|
КЦРР-1718/28.11.2012 г |
01.01.2013 |
01.01.2013 |
Неактивен |
2682 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
11.79 |
2.36 |
14.15 |
6% |
0.71 |
12.5 |
2.5 |
15 |
18% |
2.12 |
14.62 |
2.92 |
17.54 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017; НСР-17028/19.10.2018; НСР-19079/27.06.2019 |
12.07.2019 |
02.08.2019 |
Активен |
2998 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
11.85 |
2.37 |
14.22 |
6% |
0.71 |
12.56 |
2.51 |
15.07 |
18% |
2.13 |
14.69 |
2.94 |
17.63 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017; НСР-17028/19.10.2018 |
03.11.2018 |
02.12.2018 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
16.7 |
3.34 |
20.04 |
6% |
1 |
17.7 |
3.54 |
21.24 |
18% |
3.01 |
20.71 |
4.14 |
24.85 |
|
КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018; НСР-18291/28.03.2019 |
12.04.2019 |
02.05.2019 |
Активен |
1730 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
16.76 |
3.35 |
20.11 |
6% |
1.01 |
17.77 |
3.55 |
21.32 |
18% |
3.02 |
20.79 |
4.16 |
24.95 |
|
КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г.; НСР-16124/13.07.2018 |
28.07.2018 |
02.08.2018 |
Неактивен |
1730 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
11.93 |
2.39 |
14.32 |
6% |
0.72 |
12.65 |
2.53 |
15.18 |
18% |
2.15 |
14.8 |
2.96 |
17.76 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016; НСР-13274/20.07.2017 |
04.08.2017 |
02.09.2017 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
16.94 |
3.39 |
20.33 |
6% |
1.02 |
17.96 |
3.59 |
21.55 |
18% |
3.05 |
21.01 |
4.2 |
25.21 |
|
КЦРР-2557/14.03.2013; НСР-12476/28.04.2017 г. |
13.05.2017 |
02.06.2017 |
Неактивен |
1730 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
12.01 |
2.4 |
14.41 |
6% |
0.72 |
12.73 |
2.55 |
15.28 |
18% |
2.16 |
14.89 |
2.98 |
17.87 |
|
НСР-8323/26.02.2016; НСР-10750/27.10.2016 |
02.12.2016 |
02.12.2016 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
17.21 |
3.44 |
20.65 |
6% |
1.03 |
18.24 |
3.65 |
21.89 |
18% |
3.1 |
21.34 |
4.27 |
25.61 |
|
КЦРР-2557/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
1730 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
12.03 |
2.41 |
14.44 |
6% |
0.72 |
12.75 |
2.55 |
15.3 |
18% |
2.17 |
14.92 |
2.98 |
17.9 |
|
НСР-8323/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
20000247 |
Engerix B, Suspension for injection, 20 mcg/1.0 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals s.a., Белгия |
17.21 |
3.44 |
20.65 |
6% |
1.03 |
18.24 |
3.65 |
21.89 |
18% |
3.1 |
21.34 |
4.27 |
25.61 |
|
КЦРР-2557/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
1730 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0.5 ml, -, Pack: 1 pre-filled syringe |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
12.03 |
2.41 |
14.44 |
6% |
0.72 |
12.75 |
2.55 |
15.3 |
18% |
2.17 |
14.92 |
2.98 |
17.9 |
|
НСР-8323/26.02.2016 |
16.03.2016 |
16.03.2016 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0,5 ml, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A., Белгия |
10.37 |
2.07 |
12.44 |
6% |
0.62 |
10.99 |
2.2 |
13.19 |
18% |
1.87 |
12.86 |
2.57 |
15.43 |
|
НСР-2807/17.02.2014 |
03.03.2014 |
03.03.2014 |
Активен |
2516 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, 10 mcg/0,5 ml, mg, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals S.A., Белгия |
10.37 |
2.07 |
12.44 |
6% |
0.62 |
10.99 |
2.2 |
13.19 |
18% |
1.87 |
12.86 |
2.57 |
15.43 |
|
НСР-2807/17.02.2014 |
03.03.2014 |
03.03.2014 |
Неактивен |
2516 |
| Hepatitis B, purified antigen |
20000246 |
Engerix B, Suspension for injection, Hepatitis B surface antigen - 10 mcg/ 0.5 ml, -, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
12.18 |
2.44 |
14.62 |
6% |
0.73 |
12.91 |
2.58 |
15.49 |
18% |
2.19 |
15.1 |
3.02 |
18.12 |
|
НСР-3980/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
2998 |
| Hepatitis B, purified antigen |
II-10803 / 12.05.2005 г. |
Engerix B, Suspension for injection, Hepatitis B surface antigen - 20 mcg/ 1.0 ml, -, Pack: 1 |
GlaxoSmithKline Biologicals S.A., Белгия |
GlaxoSmithKline Biologicals, rue de l'Institut 89, 1330 Rixensart, Belgium |
21.01 |
4.2 |
25.21 |
6% |
1.26 |
22.27 |
4.45 |
26.72 |
18% |
3.78 |
26.05 |
5.21 |
31.26 |
|
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
1730 |